130 filings
8-K
RNAZ
TransCode Therapeutics Inc
5 Apr 24
TransCode Therapeutics Reports 2023 Results; Provides Business Update
4:51pm
10-K
2023 FY
RNAZ
TransCode Therapeutics Inc
Annual report
1 Apr 24
5:10pm
8-K
RNAZ
TransCode Therapeutics Inc
31 Jan 24
Nasdaq Determines TransCode Therapeutics Compliance with Minimum Stockholders’ Equity Requirement and Continued Listing on The Nasdaq Stock Market
4:33pm
8-K
RNAZ
TransCode Therapeutics Inc
22 Jan 24
TransCode Therapeutics Announces Pricing of $7.25 Million Public Offering
4:45pm
424B4
RNAZ
TransCode Therapeutics Inc
19 Jan 24
Prospectus supplement with pricing info
9:57pm
EFFECT
sv0ps8 kt
19 Jan 24
Notice of effectiveness
12:15am
CORRESP
4qornyc io0978sfufb
17 Jan 24
Correspondence with SEC
12:00am
CORRESP
f950d76fmy0
17 Jan 24
Correspondence with SEC
12:00am
8-K
dzu8qy4 3c
16 Jan 24
TransCode Therapeutics Announces 1-for-40 Reverse Stock Split
4:01pm
UPLOAD
pju8lyid909jwai hkjw
16 Jan 24
Letter from SEC
12:00am
8-K
yt529ip9qqbc87
8 Jan 24
Submission of Matters to a Vote of Security Holders
4:01pm
DEFA14A
zeg641z z8tq
4 Jan 24
Additional proxy soliciting materials
12:41pm
8-K
19118yj6kv15qawi2
8 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:56pm
8-K
umav9kpdenlgi
4 Dec 23
TransCode Therapeutics Announces $1.2 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
5:07pm
424B5
aj05hlm
1 Dec 23
Prospectus supplement for primary offering
5:23pm